Nitrendipin Ratiopharm (Nitrendipine)

Nitrendipine is used to manage hypertension, a condition characterized by chronically elevated arterial pressure.

• Hypertension: lowers systolic and diastolic blood pressure, improving vascular resistance and reducing risk of cardiovascular events.

• Nitrendipine selectively blocks L‑type calcium channels in vascular smooth‑muscle cells. By inhibiting calcium influx, it prevents contraction of arterial smooth muscle, causing peripheral vasodilation. The resulting fall in systemic vascular resistance leads to a reduction in arterial blood pressure, the primary therapeutic effect in hypertensive patients.

Nitrendipine may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects

• Headache: mild to moderate intensity.
• Flushing: transient warmth and redness of the skin.
• Peripheral edema: swelling of the ankles or feet.
• Dizziness or light‑headedness, especially on standing.
• Nausea: occasional gastrointestinal upset.
• Tachycardia: increased heart rate.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure requiring medical attention.
• Angioedema: swelling of the face, lips, tongue or throat.
• Myocardial infarction: rare occurrence of heart attack.
• Liver dysfunction: abnormal liver enzymes or hepatitis.
• Allergic reactions: rash, itching, or anaphylaxis.

When prescribing Nitrendipine, clinicians should consider several precautionary measures to ensure safe use.

• Blood pressure monitoring: regularly assess to avoid excessive hypotension.
• Gradual dose adjustments: titrate slowly to minimize orthostatic symptoms.
• Hepatic impairment: use with caution in patients with liver dysfunction.
• Elderly patients: start at a lower dose due to increased sensitivity.
• Concomitant CYP3A4 inhibitors: avoid or adjust dose as they may raise plasma levels.
• Store below 25°C: keep in the original packaging, protect from moisture and heat.

Nitrendipine can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

• Other antihypertensives (e.g., ACE inhibitors, beta‑blockers): may cause additive hypotensive effects.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): increase nitrendipine plasma concentrations.
• Grapefruit juice: can markedly raise drug levels and risk of adverse events.

Moderate Interactions (Monitor Closely)

• Diuretics: may enhance electrolyte disturbances and orthostatic hypotension.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): can attenuate the antihypertensive response.
• Beta‑blockers: may require dose adjustments due to combined heart‑rate effects.